أرسل هذا في رسالة قصيرة: Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer

 __   __     ___      _  _    __   __            
 \ \\/ //   / _ \\   | \| ||  \ \\/ //     ___   
  \   //   | / \ ||  |  ' ||   \ ` //     /   || 
  / . \\   | \_/ ||  | .  ||    | ||     | [] || 
 /_//\_\\   \___//   |_|\_||    |_||      \__ || 
 `-`  --`   `---`    `-` -`     `-`'       -|_|| 
                                            `-`